Filing Details

Accession Number:
0001384101-19-000170
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-31 16:09:00
Reporting Period:
2019-12-27
Accepted Time:
2019-12-31 16:09:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1543503 Keith Kennedy 6000 Shoreline Court, Suite 300
South San Francisco CA 94080
Coo / Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-27 400 $7.47 110,103 No 4 M Direct
Common Stock Disposition 2019-12-27 400 $30.00 109,703 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-12-27 400 $0.00 400 $7.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
51,442 2026-12-05 No 4 M Direct
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.
  2. Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.02. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  3. The option began to vest on December 6, 2017 and vests at a rate of 1/36th of the total number of shares subject to the award each month, subject to the continuing employment of the reporting person on each vesting date.